EBD Group is part of the KNect365 of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
ChinaBio Partnering Forum ChinaBio Group EBD Group ChinaBio Partnering Forum
Share/Follow Us
Share this:
Follow this event:

ChinaBio® Partnering Forum Press Releases

March 14, 2016ChinaBio® Partnering Forum 2016 returning to Suzhou, China's life science hub, May 18–19, 2016 The 8th annual ChinaBio® Partnering Forum 2016 life science partnering event will return to Suzhou, China, May 18–19. Suzhou is an active biopharma hub and the home of international and China pharmaceutical and medical companies, specializing in drug discovery, diagnostics, and medical devices. China is now the world's second largest and fastest growing major pharma market a...  more ►

June 11, 2015Spotlight on Suzhou Business Facts Population Suzhou, in China's Jiangsu Province, has a population of more than 5 million inhabitants and had a growth rate in excess of 6 percent per year between 2000 and 2014, according to 2014 UN data. BioBay innovation cluster BioBay, located in the Dushu Lake Science and Education Innovation District in Suzhou, is an innovative science and technology carrier for developmen...  more ►


partnering360® Blog

April 29, 2016 Digital Health: Still a brave new world At this year’s BIO-Europe Spring® panel on “The Convergence of Therapeutics and Digital Health,” two panelists from big pharma joined two from Scandinavian digital health companies, agreeing that while the platform for digital health technologies is strong in Europe, much... more ►

April 19, 2016 The characteristics of a “winning” biotech startup QureTech Bio AB, a startup developing first line drugs to combat antibiotic resistance and infectious diseases, won the Start-up Slam: Sweden biotech competition at BIO-Europe Spring® 2016 in Stockholm, Sweden earlier this month. QureTech Bio AB participated in the pitching competition sponsored by... more ►

April 5, 2016 Images of BIO-Europe Spring® 2016 in Stockholm [See image gallery at www.partnering360.com] more ►

April 5, 2016 BIO-Europe Spring® 2016 Monday recap BIO-Europe Spring® 2016 kicked off in Stockholm, Sweden yesterday with a full program and hundreds of partnering meetings.   Morning workshops ranged from new partnerships and market access to precision medicine and vaccine development.   Mid-morning, the Stockholm Business Region... more ►

April 2, 2016 Is it possible to create new business out of clinical needs? Guest post by Björn Varnestig, CEO, Flemingsberg Science   During a period of three years, we let a group of experienced business developers (we call them business architects) walk the corridors of the Karolinska University Hospital, talking to people about the problems, needs and... more ►



partnering360:Insight Latest headlines from partnering360:Insight

April 28, 2016 PledPharma seeks partner for lead therapy Jacques Näsström, CEO of PledPharma, chats with Sten Stovall about the company’s current hunt for licensing partners for lead product PledOx (calmangafodipir). more ►

April 28, 2016 Affibody CEO describes three-year growth plan Affibody CEO David Bejker discusses the biotech's four key drug and diagnostic development programs and future plans for growing the company's portfolio of antibody mimetics. more ►

April 28, 2016 New VC bioqube on open innovation roots and investments targets Nico Vandervelpen, managing partner and co-founder of bioqube ventures, and Informa Pharma Intelligence's Mike Ward discuss the young venture capital firm's big plans for the future. more ►

April 28, 2016 QureTech Bio explains novel approach to antibiotic development CEO of QureTech Bio Dr. Fritiof Pontén explains how his company's novel class of antibacterial agents might help provide a solution to the current global crisis of antibiotic resistance. more ►

April 28, 2016 CEVEC CEO talks US deals to expand business CEVEC chief Frank Ubags speaks with Scrip's Lucie Ellis about how the platform technology company is enabling gene therapy companies to move their products into large scale clinical trials. more ►



Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use